whole general disease summary Flashcards

1
Q

Describe muscular dystrophies

A

A group of genetic disorders causing muscle weakness and wasting, categorized into congenital muscular dystrophies affecting molecules interacting with dystrophin and muscularrophies affecting dystin directly.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

What are the two types of muscular dystrophies?

A

Congenital muscular dystrophies and muscular dystrophies

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Define congenital muscular dystrophy and its association with laminin

A

Congenital muscular dystrophy is linked to laminin, a protein in the basement membrane of skeletal muscle cells that helps hold cells together and attached to surrounding structures.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

How does absence or in-frame deletions of laminin α2 chains contribute to congenital muscular dystrophy?

A

Absence or in-frame deletions result in poor binding to dystroglycan and weak binding to integrins, affecting muscle stability.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Why is the disruption of integrins a problem in muscular dystrophies?

A

Disruption of integrins leads to loss of structural integrity, impaired cell signaling, muscle fiber instability, and compromised transmission of force at myotendinous junctions.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Describe the genetic mutations causing muscular dystrophies

A

Muscular dystrophies are caused by genetic mutations in the dystrophin gene, a large gene on the X chromosome with 79 exons and 2 million base pairs.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

How does the absence of dystrophin in Duchenne muscular dystrophy differ from misshapen dystrophin in Becker muscular dystrophy?

A

Duchenne has no dystrophin due to nonsense or frame shift mutations, while Becker has misshapen dystrophin allowing some functional dystrophin production.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Why is the absence of dystrophin a problem in muscular dystrophies?

A

Absence of dystrophin leads to unstable sarcolemma, cell death, muscle fibrosis, and atrophy due to the loss of structural support and stability.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Describe the diagnostic methods for muscular dystrophies

A

Diagnosis involves clinical signs like waddling gait, blood tests for elevated creatine kinase, genetic testing for dystrophin and laminin genes, and muscle biopsy showing connective tissue changes and muscle degeneration.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

What are the treatment options for muscular dystrophies?

A

Treatment includes physiotherapy for quality of life, glucocorticoids to slow degeneration, and potential therapies like gene therapy and exon skipping to introduce functional dystrophin genes.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Describe the strategy of using aminoglycosides to bypass premature stop codons in genetic disorders.

A

Aminoglycosides can help restore dystrophin in some cases by allowing the ribosome to read through premature stop codons.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Define stem cell therapy in the context of muscle tissue regeneration.

A

Stem cell therapy involves transplanting stem cells to regenerate damaged muscle tissue.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

How is collagen synthesized in the body?

A

Collagen synthesis involves transcription and translation of collagen mRNA into pre-collagen, followed by post-translational modifications like hydroxylation, glycosylation, and formation of the triple helix.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Describe the characteristics of connective tissue disorders related to collagen types 1-5.

A

Connective tissue disorders involve collagen types 1-5, with specific roles in skin, tendons, organs, bones, cartilage, reticular fibers, basal lamina, cell surfaces, hair, and placenta.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

What are the diagnostic methods and treatments for Ehlers-Danlos syndrome?

A

Diagnostic methods for Ehlers-Danlos syndrome include examining symptoms, joints, skin, and genetic testing. Treatments may involve supportive care like physiotherapy and orthopaedic instruments.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Explain the characteristics and genetic basis of Osteogenesis imperfecta.

A

Osteogenesis imperfecta is characterized by low bone mass, increased bone fragility, and mutations in COL1A1 or COL1A2 genes affecting collagen production. It is diagnosed through genetic testing and X-rays, with treatments focusing on bone health.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

Describe the clinical features and genetic mutation associated with Marfan’s syndrome.

A

Marfan’s syndrome presents with tall stature, long limbs, heart, eye, lung, and skeletal issues due to a mutation in the FBN1 gene on chromosome 15, affecting fibrillin 1 production.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

What are ion channels and their importance in physiological processes?

A

Ion channels are integral membrane proteins that allow ions to pass through cell membranes, influencing processes like muscle contraction and neuronal communication by maintaining membrane potentials.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

How do ligand-gated ion channels function, and what neurotransmitter activates them?

A

Ligand-gated ion channels, like GABA receptors, are activated by neurotransmitters such as GABA, leading to the opening of chloride channels and an inhibitory effect.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

Explain the role of voltage-gated ion channels and their activation mechanism.

A

Voltage-gated ion channels open in response to membrane potential depolarization, allowing ions like sodium to enter the cell. They are stimulated by neurotransmitter binding to receptors causing depolarization.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

Describe how channelopathies arise.

A

Channelopathies arise mainly from genetic mutations affecting ion channels, which can lead to gain of function or loss of function mutations. These mutations can occur in the promoter region, coding sequence, ligands, or modulators of ion channels.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

Define channelopathies.

A

Channelopathies are diseases of ion channels, most of which are monogenic diseases caused by mutations. They can result in various types of mutations that affect the function of channels.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

How do skeletal muscle channelopathies like myasthenia gravis affect muscle contraction?

A

In myasthenia gravis, the immune system attacks nicotinic acetylcholine receptors on muscle cells, preventing them from binding acetylcholine and causing muscle weakness and fatigue from repetitive movements.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

Explain myotonia congenita and how it affects muscle contraction.

A

Myotonia congenita is characterized by muscle contraction without the ability to relax. It can be caused by mutations in Na+ or Cl- channels, leading to delayed relaxation and sustained muscle contraction.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
25
Q

Describe how neuropathic pain is transmitted and perceived.

A

Neuropathic pain is transmitted through sensory neurons with cell bodies in the dorsal root ganglion. It is perceived due to changes in neurotransmitter release and receptor activity, leading to increased sensitivity to pain and abnormal pain responses.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
26
Q

How do Na+ ion channels, specifically NAV1.7, contribute to extreme pain disorders?

A

NAV1.7 channels, encoded by SCN9A, can mutate to cause gain of function, resulting in persistent ion currents and extreme pain disorders like erythromelalgia. Loss of function mutations in NAV1.7 can lead to insensitivity to pain.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
27
Q

Explain the role of GABA in neuropathic pain.

A

In neuropathic pain, GABA acts as an excitatory stimulus instead of its usual inhibitory role, depolarizing the membrane and causing constant pain signaling. This imbalance between excitation and inhibition can lead to the perception of pain.

28
Q

Describe the symptoms and characteristics of erythromelalgia.

A

Erythromelalgia is characterized by episodes of redness, swelling, and extreme pain, particularly in the limbs. It is associated with mutations in NAV1.7 channels that lead to persistent depolarization and pain.

29
Q

How does small fibre neuropathy affect temperature perception?

A

Small fibre neuropathy can result in pain attacks where patients cannot distinguish between hot and cold temperatures. Partial closure of NAV1.7 channels leads to continuous action potential firing and neuronal degeneration over time.

30
Q

Describe the patch clamp test.

A

It is used to study the electrical properties of individual ion channels in cells by measuring ionic currents through single or multiple ion channels.

31
Q

What is the structure of haemoglobin in adults?

A

Haemoglobin in adults has an α2β2 structure.

32
Q

Explain the mechanism of sickle cell anaemia.

A

It is caused by a single amino acid substitution in the β-globin of Hb, Glu → Val at position 6, leading to polymerization of HbS under low oxygen conditions.

33
Q

What are the symptoms of sickle cell anaemia?

A

Symptoms include pain, fatigue, swelling at sites of blockages, and infections.

34
Q

Define α-Thalassaemia.

A

It is a genetic blood disorder characterized by reduced or absent production of alpha-globin chains.

35
Q

Describe the mechanism of β-Thalassaemia.

A

It is caused by reduced or absent beta-globin chain production, leading to an excess of alpha-globin chains that precipitate inside blood cell precursors.

36
Q

What are the symptoms of β-Thalassaemia?

A

Symptoms include anaemia, jaundice, splenomegaly, skeletal changes, and iron overload.

37
Q

Describe the difference between Haemophilia Type A and Type B.

A

Type A is characterized by a deficiency or dysfunction in clotting factor 8, while Type B is characterized by a deficiency or dysfunction in clotting factor 9.

38
Q

How is Haemophilia inherited?

A

Haemophilia is an X-linked recessive disorder, with genes for clotting factors 4 and 8 located on the X chromosome.

39
Q

Define DVT in the context of thrombosis.

A

DVT stands for Deep Vein Thrombosis, which is a clot that forms in the deep veins, commonly in the legs.

40
Q

What is the primary function of platelets in the blood coagulation cascade?

A

Platelets aggregate to form a plug at injured blood vessels, initiating primary hemostasis.

41
Q

Describe the process of secondary hemostasis in the blood coagulation cascade.

A

Secondary hemostasis involves the formation of a fibrin mesh by the coagulation cascade.

42
Q

What is the genetic basis of Alkaptonuria?

A

Alkaptonuria is an autosomal recessive disease affecting tyrosine metabolism.

43
Q

How does Alkaptonuria manifest in individuals?

A

Alkaptonuria leads to the accumulation of homogentisic acid in the body, resulting in dark pigmented urine and arthritis in later life.

44
Q

Define Methylmalonic Acidaemia and its causes.

A

Methylmalonic Acidaemia is caused by a defect in methylmalonyl-CoA mutase or a defect in the synthesis of its co-factor adenosyl-cobalamin, leading to the breakdown of propionyl-coA into methylmalonic acid.

45
Q

What are the symptoms of Congenital Hypothyroidism?

A

Symptoms include stunted growth, intellectual difficulties, and abnormal thyroid development.

46
Q

How is Congenital Hypothyroidism treated?

A

Congenital Hypothyroidism is treated with oral T4 taken daily to normalize TSH levels from early life.

47
Q

Describe Phenylketonuria.

A

Phenylketonuria is an autosomal recessive disease characterized by the accumulation of the amino acid phenylalanine, leading to abnormal brain development, intellectual disorders, and neonatal vomiting.

48
Q

What is the mechanism behind Phenylketonuria?

A

Mutations in phenylalanine hydroxylase prevent the breakdown of phenylalanine into tyrosine, resulting in the production of phenyl pyruvate. This leads to elevated phenylalanine levels, which interfere with neurotransmitter synthesis.

49
Q

How is Phenylketonuria diagnosed?

A

Phenylketonuria is screened for 24 hours after birth through newborn screening (NBS) and confirmed using tandem mass spectrometry (tandem MS).

50
Q

Define Maple syrup urine disease and its symptoms.

A

Maple syrup urine disease is a disorder characterized by a defective metabolism of branched-chain amino acids (Valine, Leucine, Isoleucine), leading to symptoms such as vomiting, convulsions, intellectual development issues, and a distinctive maple syrup-like odor in urine.

51
Q

What is the defect in Maple syrup urine disease?

A

Maple syrup urine disease results from a defect in branched chain alpha-ketoacid dehydrogenase (BCKD), which is responsible for removing carboxyl groups from alpha-ketoacids to facilitate their conversion into acyl-CoA.

52
Q

Describe the diagnosis and treatment of Maple syrup urine disease.

A

Maple syrup urine disease is diagnosed using tandem mass spectrometry for branched-chain amino acids. Treatment involves limiting protein intake and in severe cases, liver transplant.

53
Q

Explain Medium-chain Acyl CoA dehydrogenase deficiency and its consequences.

A

Medium-chain Acyl CoA dehydrogenase deficiency is an autosomal recessive disorder caused by mutations in the ACADM gene. It leads to the accumulation of medium-chain fatty acids due to interrupted fatty acid oxidation, resulting in symptoms like vomiting, lethargy, and seizures.

54
Q

How is Medium-chain Acyl CoA dehydrogenase deficiency diagnosed and treated?

A

Diagnosis of Medium-chain Acyl CoA dehydrogenase deficiency is done through newborn screening and confirmed with genetic testing. Treatment involves avoiding fasting, following a low-fat high-carb diet, and having frequent meals.

55
Q

Define Familial hypercholesterolaemia and its genetic basis.

A

Familial hypercholesterolaemia is an autosomal dominant disease characterized by high blood concentrations of LDL due to mutations in the LDL receptor gene, leading to increased risk of coronary heart disease.

56
Q

Describe the consequences of Familial hypercholesterolaemia on the cardiovascular system.

A

In Familial hypercholesterolaemia, the inability to remove LDL from the bloodstream leads to the formation of atherosclerotic plaques, which can rupture, cause blood clots, and lead to conditions like strokes and myocardial infarction.

57
Q

Describe the symptoms of xanthomas.

A

Xanthomas are yellow skin deposits caused by the buildup of cholesterol in tissues.

58
Q

How is Liddle’s disease inherited?

A

Liddle’s disease is inherited in an autosomal dominant manner.

59
Q

Define ubiquitination.

A

Ubiquitination is the process where ubiquitin is attached to a protein, marking it for degradation.

60
Q

What is the role of E3 in the ubiquitination process?

A

E3 (ubiquitin ligase) binds to the target protein and brings E2 and ubiquitin close to facilitate ubiquitin attachment.

61
Q

What is the treatment for Liddle’s disease?

A

The treatment for Liddle’s disease includes a low sodium diet and potassium-sparing diuretics.

62
Q

Describe the function of statins in treating high cholesterol.

A

Statins inhibit cholesterol synthesis in the liver, which requires the presence of some LDL receptors.

63
Q

How does the ubiquitin system target proteins for destruction?

A

The ubiquitin system attaches to intracellular proteins, marking them for proteolysis and degradation.

64
Q

What is the consequence of the mutation causing Liddle’s disease?

A

The mutation in Liddle’s disease leads to increased sodium uptake, resulting in hypotension and hypokalemia.

65
Q

Define polyubiquitination.

A

Polyubiquitination involves the addition of chains of ubiquitin molecules, typically at lysine 48 of the target protein, marking it for degradation.

66
Q

How is ubiquitin activated before being attached to a protein?

A

Ubiquitin is activated by forming a thioester bond with E1 (ubiquitin-activating enzyme) and ATP before being transferred to E2 (conjugating enzyme).